Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 12.20
-0.15 (-1.21%)
At close: Aug 8, 2025, 2:57 PM CST
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 27.05 billion as of August 14, 2025. Its market cap has decreased by -1.09% in one year.
Market Cap
27.05B
Enterprise Value
27.33B
Revenue
5.53B
Ranking
n/a
PE Ratio
20.21
Stock Price
12.20
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 27.05B, an increase of 21.09%. That is a compound annual growth rate of 7.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 27.05B | 2.41% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 405.72B |
| Shenzhen Mindray Bio-Medical Electronics | 283.36B |
| WuXi AppTec | 267.28B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.39B |
| Aier Eye Hospital Group | 120.10B |
| Sichuan Biokin Pharmaceutical | 118.80B |
| Shanghai United Imaging Healthcare | 107.56B |
| Yunnan Baiyao Group Co.,Ltd | 99.83B |